Other OTC Pharmaceuticals - Italy

Italy

Highlights

In Italy, the revenue generated in the market Other OTC Pharmaceuticals amounted to US$1.52bn in 2024.
It is projected to experience an annual growth rate of 0.71% (CAGR 2024-2029).
When compared to other countries around Worldwide, the United States leads with a revenue of US$7.17bn in 2024.
In terms of per capita figures, each person in Italy contributed US$25.88 to the revenue in 2024.
Italy's OTC Pharmaceuticals market is currently experiencing a surge in demand for herbal remedies and natural health products.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in Italy is experiencing steady growth due to several factors.

Customer preferences: Italian consumers have shown a preference for over-the-counter (OTC) pharmaceuticals for minor ailments and self-treatment. This is driven by factors such as convenience, cost-effectiveness, and the desire for quick relief from common health issues. OTC products offer a wide range of options for consumers to address their specific needs without the need for a prescription.

Trends in the market: One notable trend in the Other OTC Pharmaceuticals market in Italy is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of their health and are seeking products with natural ingredients that are perceived to be safer and have fewer side effects. This trend is in line with the global shift towards natural and organic products.Another trend is the rising popularity of online retail channels for purchasing OTC pharmaceuticals. E-commerce platforms provide convenience and a wide variety of products for consumers to choose from. The COVID-19 pandemic has further accelerated this trend as people turned to online shopping to avoid physical stores and reduce the risk of exposure.

Local special circumstances: Italy has a well-established healthcare system that provides universal coverage for its citizens. However, the system is burdened with long waiting times and limited access to certain medications. This has led to an increased reliance on OTC pharmaceuticals for minor ailments and self-treatment. Additionally, the Italian population is aging, which has resulted in a higher demand for OTC products that cater to the specific health needs of older individuals.

Underlying macroeconomic factors: Italy has a stable economy with a high standard of living. The country has a strong pharmaceutical industry that contributes to the growth of the Other OTC Pharmaceuticals market. Furthermore, the Italian government has implemented regulations that ensure the safety and efficacy of OTC products, which instills confidence in consumers.In conclusion, the Other OTC Pharmaceuticals market in Italy is driven by customer preferences for convenience and cost-effectiveness, as well as the increasing demand for natural and herbal remedies. The rise of online retail channels and the country's well-established healthcare system also contribute to the market's growth. Overall, the market is expected to continue expanding as consumers seek accessible and effective solutions for their health needs.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.